Please turn JavaScript on
header-image

Born2Invest

Want to keep yourself up to date with the latest news from Born2Invest?

Subscribe using the "Follow" button below and we provide you with customized updates, via topic or tag, that get delivered to your email address, your smartphone or on your dedicated news page on follow.it.

You can unsubscribe at any time painlessly.

Title of Born2Invest: "Born2Invest | #1 Business and Finance News | Best Breaking News"

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  2.85 / day

Message History

Quick Disclosure: We’re about to tell you about some great Technology Affiliate Programs. Just know that if you click on our Technology Affiliate Program links, we may earn a small commission. Your choice.

This week, we’re going to talk about technology.

Specifically, techno...


Read full story

South Africa is taking another step toward fully standardizing its cannabis laws. The Ministry of Justice has just published draft regulations. The document, dated February 2nd, 2026, specifies the amount of cannabis that can be legally possessed and cu...


Read full story

In its third edition, the SwissHacks 2026 hackathon gains additional importance as a cornerstone of the Swiss FinTech Week.

The first two SwissHacks events in 2024 and 2025 were very well attended and successfully held. The 2026 edition takes on additional significance as the opening event of Swiss FinTech Week in Zurich.

The Swiss FinTech Week will premie...


Read full story

CDP’s Board of Directors has approved operations worth approximately €1.5 billion. The resources will go to strategic businesses, renewables, and international cooperation.

A new package of operations worth approximately €1.5 billion was approved by the Board of Directors of Cassa Depositi e Prestiti. The resources will be used to strengthen strategic industrial sec...


Read full story

A report prepared by Milena Richter for the European Federation of Pharmaceutical Industries and Associations (EFPIA) paints a picture of urgency for the sector on the continent. The biopharma industry is facing a period of threats to European security within a context of macroeconomic and geoeconomic challenges. Over the last two decades,


Read full story